Physician profile

Brian C Werner

Sports Medicine (Orthopaedic Surgery) · Charlottesville, VA

NPI 1245474584

$1,210,223.44

in general payments reported to CMS, 2019-2025

34 companies · $565K in 2025

The $565K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$560,083.84
Consulting Fee$229,111.52
Travel and Lodging$90,507.49
Food and Beverage$11,624.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $1,186,623.77 2019-2025 Arthrex, Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems
Pacira Pharmaceuticals Incorporated $8,501.48 2022
Lifenet Health $6,873.89 2022-2025 Speedflex
Fortis Surgical, LLC $2,505.14 2019-2025
Stryker Corporation $579.27 2023-2025 Alphavent, Samurai, Salvation
Cgg Medical INC $478.98 2025
Kci USA, INC. $425.00 2021
Pinnacle, INC $419.66 2022-2023
Zimmer Biomet Holdings, INC. $316.65 2019-2023 Tapestry
Exactech, INC. $305.64 2019-2022
Gentleman Orthopedic Solutions $266.34 2022-2023
Active Medical, LLC $215.01 2025
Conetic Solutions, INC. $212.22 2024-2025
Peerless Surgical INC. $203.72 2023-2024
Sioux Surgical INC $201.95 2024
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Supreme Orthopedic Systems, LLC $182.19 2023-2025
Enduromed, LLC $175.52 2024
Reel Surgical, INC. $171.42 2025
Lightbody Medical Technologies INC $149.97 2024
Core Surgical Group $146.02 2025
Prime Surgical, LLC $135.24 2025
Cosa Medical, LLC $129.06 2025
Suvon Surgical LLC $125.82 2024
Titan Surgical Group, LLC $125.72 2021
True North Surgical INC $122.50 2025
Pylant Medical $120.65 2021
Legacy Ortho LLC $114.64 2025
Ossio INC $107.26 2023
Sawtooth Surgical Solutions INC $106.00 2025
Piedmont Plus Innovation $55.10 2023
Pacira Therapeutics, INC. $50.00 2019
Saxum Surgical, INC. $45.05 2023
Ipsen Biopharmaceuticals, INC $32.56 2024 Dysport

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$50,444.95 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brian C Werner

$1,210,223.44

in general payments reported 2019-2025

Years
2019-2025
Top company
Arthrex, INC.
Context
The $565K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).

https://glasscript.com/doctor/1338423/brian-c-werner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.